Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Status:
Recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to
evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC
infants.